UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report: April 18, 2007
UROPLASTY, INC.
(Exact name of registrant as specified in charter)
| |
|
|
000-20989
(Commission File No.)
|
|
41-1719250
(IRS Employer Identification No.) |
Minnesota
(State or other jurisdiction of incorporation or organization)
5420 Feltl Road
Minnetonka, Minnesota 55343
(Address of principal executive offices)
952-426-6140
(Registrant’s telephone number, including area code)
Not Applicable
(Former Name and Address)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
| |
|
o Written communications pursuant to Rule 425 of the Securities Act (17 CFR 230.425) |
| |
| |
|
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
| |
|
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
| |
|
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
TABLE OF CONTENTS
Item 2.02 Results of Operations and Financial Condition
On April 18, 2007, the company issued a press release regarding preliminary net sales results
for the quarter and full fiscal year ended March 31, 2007. The press release summarizes the key
matters discussed publicly during the company’s conference call (previously publicized in
accordance with Regulation F-D) held on April 16, 2007.
Item 8.01 Other Events
The press release described above also includes other business information regarding the
company, including a description of strategic objectives for fiscal 2008 and net sales projections
for fiscal 2008.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
| |
|
|
| Exhibit No. |
|
Description |
99.1
|
|
Press Release dated April 18, 2007 (filed herewith, except as to the
information included in such press release regarding unaudited net sales for the
quarter and full fiscal year ended March 31, 2007, which information is furnished
herewith). |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
Dated: April 18, 2007
| |
|
|
|
|
| |
Uroplasty, Inc.
|
|
| |
By /s/ David B. Kaysen
|
|
| |
David B. Kaysen, President and |
|
| |
Chief Executive Officer |
|
| |